ERBITUX vs OPDIVO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. ERBITUX and OPDIVO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ERBITUX	OPDIVO
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CETUXIMAB	NIVOLUMAB
Manufacturer	Imclone	Bristol Myers Squibb
Dosage forms	Solution	Injectable
Drug class	—	Programmed Death Receptor-1 Blocking Antibody
Boxed warning	Boxed warning	None
Treats	Squamous Cell Carcinoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

erbitux opdivo

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

CETUXIMAB

NIVOLUMAB

Manufacturer

Imclone

Bristol Myers Squibb

Dosage forms

Solution

Injectable

Drug class

—

Programmed Death Receptor-1 Blocking Antibody

Boxed warning

None

Treats

Squamous Cell Carcinoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

Frequently asked questions

What is the difference between Erbitux and Opdivo?

Erbitux contains Cetuximab, while Opdivo contains Nivolumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.